Synthesis of enzyme-degradable, peptide-cross-linked dextran hydrogels

被引:113
作者
Levesque, Stephane G.
Shoichet, Molly S.
机构
[1] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada
[2] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada
[3] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada
关键词
D O I
10.1021/bc0602127
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Hydrogels derived from synthetic polymers have been previously engineered to degrade under the activity of matrix metalloproteinases (MMPs). It is believed that these systems can act as extracellular-matrix (ECM) equivalents mimicking the degradation and remodeling of the ECM through the activity of cell-secreted enzymes. In this study, MMP-sensitive hydrogels derived from dextran were developed. In order to avoid the incorporation of hydrolyzable esters often introduced in dextran modification strategies, the polysaccharide was modified with p-maleimidophenyl isocyanate (PMPI) thereby introducing maleimide functionalities in the backbone and resulting in dextran derivatized with p-maleimidophenyl isocyanate (Dex-PMPI). This strategy was favored to separate out the effects of random hydrolysis and enzymatic digestion in the degradation of the dextran hydrogels. A peptide cross-linker, derived from collagen and susceptible to gelatinase A (MMP-2) digestion, was synthesized with bifunctional cysteine termini and used to cross-link the Dex-PMPI. These hydrogels were found to be hydrolytically stable for more than 200 days yet degraded either within 30 h when exposed to bacterial collagenase or within 16 days when exposed to human MMP-2, demonstrating enzymatic-mediated digestion of the peptide cross-links. Further modification of the cross-linked hydrogels with laminin-derived peptides enhanced cell adhesion and survival, demonstrating the potential of these materials for use in tissue engineering applications.
引用
收藏
页码:874 / 885
页数:12
相关论文
共 72 条
[1]
P-MALEIMIDOPHENYL ISOCYANATE - A NOVEL HETEROBIFUNCTIONAL LINKER FOR HYDROXYL TO THIOL COUPLING [J].
ANNUNZIATO, ME ;
PATEL, US ;
RANADE, M ;
PALUMBO, PS .
BIOCONJUGATE CHEMISTRY, 1993, 4 (03) :212-218
[2]
Extending insulin action in vivo by conjugation to carboxymethyl dextran [J].
Baudys, M ;
Letourneur, D ;
Liu, F ;
Mix, D ;
Jozefonvicz, J ;
Kim, SW .
BIOCONJUGATE CHEMISTRY, 1998, 9 (02) :176-183
[3]
Bollag D M, 1994, Methods Mol Biol, V36, P1
[4]
Crosslinked dextran - a new capsule material for colon targeting of drugs [J].
Brondsted, H ;
Andersen, C ;
Hovgaard, L .
JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) :7-13
[5]
BRUNSWICK M, 1988, J IMMUNOL, V140, P3364
[6]
Cadée JA, 2000, J BIOMED MATER RES, V50, P397
[7]
Immobilization of oligonucleotides on poly(ethylene glycol) brush-coated Si surfaces [J].
Cha, TW ;
Boiadjiev, V ;
Lozano, J ;
Yang, H ;
Zhu, XY .
ANALYTICAL BIOCHEMISTRY, 2002, 311 (01) :27-32
[8]
Synthesis and characterization of dextran-peptide-methotrexate conjugates for tumor targeting via mediation by matrix metalloproteinase II and matrix metalloproteinase IX [J].
Chau, Y ;
Tan, FE ;
Langer, R .
BIOCONJUGATE CHEMISTRY, 2004, 15 (04) :931-941
[9]
Matrix metalloproteinase production in regenerating axolotl spinal cord [J].
Chernoff, EAG ;
O'Hara, CM ;
Bauerle, D ;
Bowling, M .
WOUND REPAIR AND REGENERATION, 2000, 8 (04) :282-291
[10]
Dextran cross-linked gelatin microspheres as a drug delivery system [J].
Cortesi, R ;
Esposito, E ;
Osti, M ;
Squarzoni, G ;
Menegatti, E ;
Davis, SS ;
Nastruzzi, C .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) :153-160